Veru to Proceed With Late-Stage Study of COVID Pill Despite FDA Snub

The drug developer said it plans to proceed with a late-stage trial of its COVID-19 pill, weeks after the FDA declined to authorize the oral drug to treat high-risk patients hospitalized with COVID-19.
Reuters Health Information

source https://www.medscape.com/viewarticle/989635?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?